These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24640372)

  • 1. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
    Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
    van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
    Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS; Na YS; Yoon CS; Park JY; Kim HS; Hur MH; Lee HK; Chun YK; Kang SS; Park BW; Lee JH
    Int J Surg Pathol; 2007 Apr; 15(2):98-109. PubMed ID: 17478762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
    Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
    Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE; Zhang YJ; Cui YM; Zhang HQ
    Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
    Raica M; Cimpean AM; Ceausu R; Ribatti D
    Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
    Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.